Notable Labs Net Profit Margin 2013-2024 | NTBLQ

Notable Labs net profit margin from 2013 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Notable Labs Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2022-12-31 $-0.00B $-0.01B 1300.00%
2022-09-30 $0.00B $-0.04B inf%
2022-06-30 $0.00B $-0.04B inf%
2022-03-31 $0.00B $-0.03B inf%
2021-12-31 $0.00B $-0.03B inf%
2021-09-30 $0.00B $-0.03B inf%
2021-06-30 $0.00B $-0.03B inf%
2021-03-31 $0.00B $-0.03B inf%
2020-12-31 $0.00B $-0.02B inf%
2020-09-30 $0.00B $-0.02B inf%
2020-06-30 $0.00B $-0.02B inf%
2020-03-31 $0.00B $-0.02B inf%
2019-12-31 $0.00B $-0.02B inf%
2019-09-30 $0.00B $-0.02B inf%
2019-06-30 $0.00B $-0.02B inf%
2019-03-31 $0.00B $-0.02B inf%
2018-12-31 $0.00B $-0.02B inf%
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.000B
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00